Although extensive studies have been carried out on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and evidence exists that pregnant women are at elevated risk of severe ...
Poster Presentation Highlights the Need for a Polyclonal Hyperimmune Globulin Targeting S. Pneumoniae to Bridge Vaccination and Seroconversion Across Multiple Serotypes By Using as an Add-On with a ...
In a recent study published in the journal Vaccines, researchers in Saudi Arabia and the United States examined immune responses and immunoglobulin G (IgG) cross-reactivity in individuals infected ...
Rubella antibodies in the blood mean that a person’s immune system has developed a response to the rubella virus. A positive result for rubella immunoglobulin (IgG) antibodies means a person is immune ...
The FcRn-targeted immunotherapy market presents opportunities through innovative biologic treatments blocking FcRn-IgG interactions. This addresses high unmet needs in autoimmune diseases like ...
YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that Frontiers in Immunology has published the safety and final efficacy results from the pivotal Phase III clinical trial ...
An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...
Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results